Clinical and Molecular Characteristics of Histiocytic Disorders

Overview

About this study

The purpose of this study is to assess the presence of various molecular markers in histiocytic disorders. In addition to this, to review clinical records of the patients with these disorders to assess the role of the molecular markers in patient outcomes.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All patients diagnosed with histiocytic disorders and age ≥1 year

Exclusion Criteria: 

  • <1 year age

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ronald Go, M.D.

Open for enrollment

Contact information:

Ronald Go M.D.

Go.Ronald@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Ronald Go, M.D.

Contact us for the latest status

Contact information:

Farouk Mookadam M.D.

(480) 301-9692

Mookadam.Farouk@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20398310

Mayo Clinic Footer